🎉 M&A multiples are live!
Check it out!

Indegene Valuation Multiples

Discover revenue and EBITDA valuation multiples for Indegene and similar public comparables like Doctor Care Anywhere, Benevolent AI, and CurveBeam AI.

Indegene Overview

About Indegene

Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.


Founded

1998

HQ

India
Employees

5.2K+

Website

indegene.com

Financials

LTM Revenue $332M

LTM EBITDA $64.5M

EV

$1.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Indegene Financials

Indegene has a last 12-month revenue of $332M and a last 12-month EBITDA of $64.5M.

In the most recent fiscal year, Indegene achieved revenue of $301M and an EBITDA of $67.8M.

Indegene expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Indegene valuation multiples based on analyst estimates

Indegene P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $268M $301M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA $51.8M $67.8M XXX XXX XXX
EBITDA Margin 19% 23% XXX XXX XXX
Net Profit $19.1M $30.9M XXX XXX XXX
Net Margin 7% 10% XXX XXX XXX
Net Debt n/a $37.3M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Indegene Stock Performance

As of April 15, 2025, Indegene's stock price is INR 571 (or $7).

Indegene has current market cap of INR 137B (or $1.6B), and EV of INR 123B (or $1.4B).

See Indegene trading valuation data

Indegene Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.4B $1.6B XXX XXX XXX XXX $0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Indegene Valuation Multiples

As of April 15, 2025, Indegene has market cap of $1.6B and EV of $1.4B.

Indegene's trades at 4.3x LTM EV/Revenue multiple, and 22.1x LTM EBITDA.

Analysts estimate Indegene's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Indegene and 10K+ public comps

Indegene Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.4B XXX XXX XXX
EV/Revenue 4.4x XXX XXX XXX
EV/EBITDA 22.0x XXX XXX XXX
P/E 35.4x XXX XXX XXX
P/E/Growth 1.8x XXX XXX XXX
EV/FCF 32.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Indegene Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Indegene Valuation Multiples

Indegene's NTM/LTM revenue growth is 14%

Indegene's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $48K for the same period.

Over next 12 months, Indegene's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Indegene's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Indegene and other 10K+ public comps

Indegene Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 12% XXX XXX XXX XXX
EBITDA Margin 20% XXX XXX XXX XXX
EBITDA Growth 31% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 34% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $48K XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 83% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Indegene Public Comps

See public comps and valuation multiples for Healthcare Software and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Benevolent AI XXX XXX XXX XXX XXX XXX
Alcidion Group XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Doctor Care Anywhere XXX XXX XXX XXX XXX XXX
Echo IQ XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Indegene M&A and Investment Activity

Indegene acquired  XXX companies to date.

Last acquisition by Indegene was  XXXXXXXX, XXXXX XXXXX XXXXXX . Indegene acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Indegene

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Indegene

When was Indegene founded? Indegene was founded in 1998.
Where is Indegene headquartered? Indegene is headquartered in India.
How many employees does Indegene have? As of today, Indegene has 5.2K+ employees.
Who is the CEO of Indegene? Indegene's CEO is Mr. Manish Gupta.
Is Indegene publicy listed? Yes, Indegene is a public company listed on NSE.
What is the stock symbol of Indegene? Indegene trades under INDGN ticker.
When did Indegene go public? Indegene went public in 2024.
Who are competitors of Indegene? Similar companies to Indegene include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere.
What is the current market cap of Indegene? Indegene's current market cap is $1.6B
What is the current revenue of Indegene? Indegene's last 12-month revenue is $332M.
What is the current EBITDA of Indegene? Indegene's last 12-month EBITDA is $64.5M.
What is the current EV/Revenue multiple of Indegene? Current revenue multiple of Indegene is 4.3x.
What is the current EV/EBITDA multiple of Indegene? Current EBITDA multiple of Indegene is 22.1x.
What is the current revenue growth of Indegene? Indegene revenue growth between 2023 and 2024 was 12%.
Is Indegene profitable? Yes, Indegene is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.